These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 18720452)

  • 1. Professional development of statisticians in the pharmaceutical sector: evolution over the past decade and into the future.
    Lewis T
    Pharm Stat; 2008; 7(3):158-69. PubMed ID: 18720452
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Who wants to be an ICH Euro billionaire?
    Gordon K
    Pharm Stat; 2008; 7(1):4-8. PubMed ID: 17370280
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The draft FDA guideline on non-inferiority clinical trials: a critical review from European pharmaceutical industry statisticians.
    Huitfeldt B; Hummel J;
    Pharm Stat; 2011; 10(5):414-9. PubMed ID: 21932294
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The impact of the international guideline entitled Statistical Principles for Clinical Trials (ICH E9).
    Lewis J; Louv W; Rockhold F; Sato T
    Stat Med; 2001 Sep 15-30; 20(17-18):2549-60. PubMed ID: 11523068
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Data sharing and the evolving role of statisticians.
    Manamley N; Mallett S; Sydes MR; Hollis S; Scrimgeour A; Burger HU; Urban HJ
    BMC Med Res Methodol; 2016 Jul; 16 Suppl 1(Suppl 1):75. PubMed ID: 27410483
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Statisticians and evidence--mote and beam.
    Senn S
    Pharm Stat; 2008; 7(3):155-7. PubMed ID: 18381598
    [No Abstract]   [Full Text] [Related]  

  • 7. Advances in knowledge management for pharmaceutical research and development.
    Torr-Brown S
    Curr Opin Drug Discov Devel; 2005 May; 8(3):316-22. PubMed ID: 15892246
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Looking forward in pharmaceutical process chemistry.
    Davies IW; Welch CJ
    Science; 2009 Aug; 325(5941):701-4. PubMed ID: 19661417
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessing the impact of ICH E9.
    Brown D; Day S; Hemmings R; Wright D
    Pharm Stat; 2008; 7(2):77-87. PubMed ID: 18438957
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A course in constructing effective displays of data for pharmaceutical research personnel.
    Bradstreet TE; Nessly ML; Short TH
    Pharm Stat; 2013; 12(3):174-84. PubMed ID: 23564752
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The training of clinical trails statisticians: a clinician's view.
    Hammond D
    Biometrics; 1980 Dec; 36(4):679-85. PubMed ID: 7248436
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [ICH M4: the standardized international restration dossier or "C.T.D." (common technical document)].
    de Cremiers F
    Ann Pharm Fr; 1999 Mar; 57(2):143-6. PubMed ID: 10365470
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Innovative strategies for early clinical R&D.
    Butz RF; Morelli G
    IDrugs; 2008 Jan; 11(1):36-41. PubMed ID: 18175261
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Statisticians and pharmacokineticists: what they can still learn from each other.
    Senn S
    Clin Pharmacol Ther; 2010 Sep; 88(3):328-34. PubMed ID: 20613721
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In search of sustainability: process R&D in light of current pharmaceutical industry challenges.
    Federsel HJ
    Drug Discov Today; 2006 Nov; 11(21-22):966-74. PubMed ID: 17055405
    [TBL] [Abstract][Full Text] [Related]  

  • 16. International Conference on Harmonisation; guidance on Q10 Pharmaceutical Quality System; availability. Notice.
    Food and Drug Administration, HHS
    Fed Regist; 2009 Apr; 74(66):15990-1. PubMed ID: 19507321
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmaceutical industry, investigators and institutions: Partners or tools?
    Verweij J
    Eur J Cancer; 2005 Oct; 41(15):2204-5. PubMed ID: 16143515
    [No Abstract]   [Full Text] [Related]  

  • 18. Outcomes research collaborations between third-party payers, academia, and pharmaceutical manufacturers: What can we learn from clinical research?
    Eichler HG; Kong SX; Grégoire JP
    Eur J Health Econ; 2006 Jun; 7(2):129-35. PubMed ID: 16485122
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Statisticians in European regulatory agencies.
    Skovlund E
    Pharm Stat; 2009; 8(4):259-63. PubMed ID: 19301357
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Statistical aspects in comparative benefit-risk assessment: challenges and opportunities for pharmaceutical statisticians.
    Quartey G; Wang J
    Pharm Stat; 2012; 11(1):82-5. PubMed ID: 21997832
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.